Strumento inattivo

Altre lingue Lotus Bio-Technology Development Corp OTC Bulletin Board

Azioni

US54570R1077

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Lotus Bio-Technology Development Corp. Increases Their Footprint in the Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Pioneer Digital Health	16/02/23
Lotus Bio-Technology Development Corp. acquired Pioneer Digital Health, Inc.	16/02/23
Lotus Bio-Technology Development Corp. announced that it has received $0.05 million in funding	23/12/22
Lotus Bio-Technology Development Corp. announced that it expects to receive $0.05 million in funding	14/12/22
Lotus Bio-Technology Development Corp. announces sale of Boomerangkit.com, LLC	25/10/22
BioGnomics Lab, LLC acquired Boomerangkit.com, LLC from Lotus Bio-Technology Development Corp..	25/10/22
Lotus Bio-Technology Development Corp. Releases Shareholder Update Addressing Securities and Exchange Commission's Complaint	30/08/22
Lotus Bio Technology Development : Current Report	19/08/22
Lotus Bio-Technology Development Corp, Inc. Initiates Company Name Change	16/08/22
Lotus Bio-Technology Development Corp, Inc , Announces Resignation of Director and Surrendering of 150,000,000 Common Shares to Treasury.	16/08/22
Lotus Bio-Technology Development Corp, Inc , Announces Resignation of Zoltan Nagy as Director	16/08/22
Lotus Bio-Technology Development Corp. Announces YTD Revenues And Projections by The Newly Acquired Companies in The Digital Health And Wellness Home Testing Industry.	02/08/22
Lotus Bio-Technology Development Corp. Enters Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Focal Point, Inc. and Boomerangkit.com, LLC.	06/07/22
Lotus Bio-Technology Development Corp. Appoints Hoyt Christopher as CEO	06/07/22
Lotus Bio-Technology Development Corp. acquired Boomerangkit.com, LLC/Focal Point, Inc. from Focal Point, Inc. and Boomerangkit.com, LLC.	06/07/22
Lotus Bio Technology Development : Attorney Letter with Respect to Current Information	30/06/22
Lotus Bio-Technology Development Corp. (OTC: LBTD) (“LBTD”) Announces Entering Into a Binding Letter of Intent	13/04/22
Lotus Bio-Technology Development Corp. entered into a binding letter of intent to acquire Little Jupiter Gold Project in Nevada, USA from AMT Industries Canada Inc.	13/04/22
Lotus Bio Technology Development : BIOTECH DEVELOPMENT CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-Q/A)	07/04/21
Lotus Bio-Technology Development Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2017	07/04/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Lotus Bio-Technology Development Corp OTC Bulletin Board

Azioni

US54570R1077

Altre lingue

Filtri